Development of Clinical Marker for Perilymph Fistula

Telian, Steven A.

Abstract

Funding Agency

• Agency: National Institute of Health (NIH)
• Institute: National Institute on Deafness and Other Communication Disorders (NIDCD)
• Type: Research Project (R01)
• Project #: 5R01DC001285-03
• Application #: 3218000
• Study Section: Special Emphasis Panel (SRC (01))
• Project Start: 1991-07-15
• Project End: 1996-06-30
• Budget Start: 1993-07-01
• Budget End: 1994-06-30
• Support Year: 3
• Fiscal Year: 1993

Institution

• Name: University of Michigan Ann Arbor
• Type: Schools of Medicine
• DUNS #: 791277940
• City: Ann Arbor
• State: MI
• Country: United States
• Zip Code: 48109

Publications

Sun, Q; Disher, M J; Rustad, T et al. (1998) AP30, a differential protein marker for perilymph and cerebrospinal fluid in middle ear fluid, has been purified and identified as human apolipoprotein D. Biochim Biophys Acta 1384:405-13